Infection Control

Breaking News

Stablepharma publishes peer-reviewed article on world’s first fridge-free Tetanus diphtheria vaccine

Full recovery of vaccine potency, after 7–10 months at 45°C, was shown by complete protection against supra-lethal doses of active toxins

Partnership advances antibody therapies in immunology

Genmab and argenx have entered a multiyear collaboration, bringing together capabilities to jointly discover, develop and commercialise antibody th...

Biggest overhaul of trial regulation for 20 years

A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners

Clearing the air after half a century of containment

The past 50 years have seen a transformation in clean air and containment technology, turning it into a thriving industry. Envair’s Gary Bagshaw us...

Study published on "ultrapotent" SARS neutralising antibodies

The bioRxiv preprint details a novel, highly potent, anti-S2 camelid single-domain antibody

MDC and SMi secure grant to detect cancer biomarkers

It will transform their use for routine cancer screening and enable monitoring of treatment efficacy in real time

It’s just a wipe! Not in a cleanroom it isn’t!

Part II of a two-part article in which Karen Rossington, European Marketing Manager at Contec Inc., examines why cleanrooms and other controlled en...

Cleanroom Conference and Manufacturing Chemist Live events set to go ahead

The co-located events will go ahead in October with new safety measures in place, after being postponed from their original date at the start of su...

Poolbeg announces strategic expansion of POLB 001 into oncology

Complements strong initial data from LPS challenge trial and is in line with stated objective at IPO to expand POLB 001 to additional indications

Get ahead of the curve in 2023 with a subscription

Keep abreast of significant pharmaceutical developments around the world

Taking HEPA filter integrity tests to a new level

Dr Thomas Kosian, Senior Expert in Barrier Systems at Syntegon, and Dr-Ing. Christian Dorfner, Head of R&D at InfraSolution, discuss how the two c...

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge potential applications. Angharad Bal...

Oxford Ebola vaccine manufactured and shipped to Uganda

40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in 60 days

It’s just a wipe! Not in a cleanroom it isn’t!

Part I of a two-part article by Karen Rossington, European Marketing Manager at Contec Inc., that examines why cleanrooms and other controlled envi...

NeoVac and CPI partner next-generation RNA vaccine technology

CPI will develop scalable processes and manufacture clinical-grade batches of RNA-LNP product, focusing initially on doses to tackle new and emerge...

Future-proofing cleanroom containment technology: considerations for 2022

Driven by the rise in demand for biologics manufacturing support, particularly the increased need for vaccine filling, the global aseptic pharma pr...